Implementation Research to Enhance Equity- Focused HIV Prevention in New York City
Project Number5U01PS005239-02
Contact PI/Project LeaderGOLUB, SARIT A
Awardee OrganizationHUNTER COLLEGE
Description
Abstract Text
7.1. PROJECT SUMMARY/ABSTRACT -- CORE Project
One of the fundamental challenges to effective implementation of HIV prevention interventions is the
engagement of clients who are eligible for and would benefit most from them. This Core Project is focused on
this critical implementation problem: the need to develop and test novel implementation strategies that increase
engagement, uptake, and sustainment of proven HIV prevention interventions, including rapid testing,
PrEP/PEP, and iART. Based on a review of the research literature and data collected directly from community
members in their EHE high priority jurisdictions, the New York City Health Department (NYC HD) has identified
three core determinants of this HIV prevention implementation problem: (1) clients’ anticipated and experienced
stigma and discrimination limit acceptability and uptake; (2) providers’ implicit and explicit bias limit offers and
dissemination; and (3) systemic emphasis on siloed services and risk-based eligibility limits access and
availability. In response to this problem, the NYC HD has chosen an implementation strategy called the GOALS
Approach to Sexual Health, which is designed to: a) universalize and normalize HIV prevention conversations
and interventions; and b) disseminate a client-centered, gender-affirming, non-discriminating, anti-stigmatizing
and trauma-informed approach to sexual history and HIV prevention conversations. This Core Project uses a
two-phase cluster-randomized, stepped-wedge implementation trial to evaluate adoption of the implementation
strategy in 20 agencies funded by the NYC HD. Based on an implementation science model, we will examine
outcomes at three levels: a) implementation outcomes (e.g., rates of HIV testing, PrEP uptake, immediate linkage
of newly diagnosed patients to care); b) service outcomes (e.g., equitable distribution of HIV prevention
interventions to highest priority populations); and c) patient outcomes (e.g., impact on city-wide HIV incidence,
engagement in care, and viral suppression). Secondary analysis will also be conducted on hypothesized
mechanisms (i.e., mediators) as defined in the program’s logic model, including dimensions of provider
competence and patients’ experience. Model fidelity data will be collected on enactment of the GOALS Approach
implementation strategy by the NYC HD, and its ability to successfully implement the strategy at each of the
individual agencies. Finally, qualitative data will be collected to assess barriers and facilitators to implementation
at both the health department and agency levels to inform future adaptation and dissemination of the
implementation strategy.
7.2. PROJECT SUMMARY/ABSTRACT -- COLLABORATIVE Project
One of the most persistent challenges in health care provision is quality. It is often easy to determine which or
how many services are being provided to clients by a given agency or program, but it is far more difficult to
determine how well these services are being delivered, or what aspects of service delivery have the greatest
impact on outcomes. This Collaborative Project is based on the scientific premise that quality can be defined,
measured, and supported by a re-envisioning of health department contract practices, and that an
implementation science approach can evaluate this innovative strategy and identify its strengths and
weaknesses for broader dissemination. In this Collaborative Project, we address the persistent problem of
quality through: a) an implementation strategy that defines quality in HIV prevention services and
operationalizes a logic model through which higher quality services will address known barriers and inequities
at the community-, system-, and client-levels; b) a data collection and quality improvement and management
(QIM) strategy that focuses on quality and quality metrics as incentive-based deliverables in HIV prevention
contracts; c) a training and technical support system that works with agencies to identify challenges to quality
service provision and supports them to identify and enact approaches to address those challenges; and d) a
collaborative research design that measures initiation, adoption, and sustainment of each component of this
implementation strategy, and applies a programmatic logic model to examine the impact of each component on
hypothesized determinants, mechanisms, and outcomes. The New York City Health Department (NYC HD)
has selected a Quality-Based Financing (QBF) model to fund its HIV prevention contracts (in contrast to a
traditional fee-for-service model) as an implementation strategy to decrease inequities in access, utilization,
and outcomes for HIV prevention services, and to equitably decrease the HIV incidence among NYC’s highest
priority populations. This Collaborative Project has four main objectives: (1) conduct an interrupted time
series (ITS) analysis to evaluate the impact of implementing the QBF model; (2) qualitatively explore factors
that potentially explain differences in successful implementation of QBF across different agencies; (3) Identify
factors significantly associated with differential effectiveness of the QBF model using longitudinal multiple
regression analysis; and (4) Measure model fidelity and monitor QBF implementation at the level of the health
department and funded agencies.
Public Health Relevance Statement
8. PROJECT NARRATIVE
This project supports federal Ending the HIV Epidemic goals by: a) operationalizing health department
strategies to enhance adoption and sustainment of proven HIV prevention interventions; and b) applying a
rigorous implementation science approach to evaluate their impact. As a collaboration between an academic
research team with extensive implementation science expertise and one of the largest health departments in
the country, this project has the potential to exert a significant and sustained impact on the field by generating
findings that inform scale-up of EHE interventions to maximize accessibility, engagement, and health equity.
National Center for HIVAIDS, Viral Hepatitis, STD, and TB Prevention
CFDA Code
941
DUNS Number
620127915
UEI
EK93EZLLBSC4
Project Start Date
01-September-2021
Project End Date
31-August-2026
Budget Start Date
01-September-2022
Budget End Date
31-August-2023
Project Funding Information for 2022
Total Funding
$1,358,634
Direct Costs
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2022
National Center for HIVAIDS, Viral Hepatitis, STD, and TB Prevention
$1,358,634
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U01PS005239-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U01PS005239-02
Patents
No Patents information available for 5U01PS005239-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U01PS005239-02
Clinical Studies
No Clinical Studies information available for 5U01PS005239-02
News and More
Related News Releases
No news release information available for 5U01PS005239-02
History
No Historical information available for 5U01PS005239-02
Similar Projects
No Similar Projects information available for 5U01PS005239-02